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Abstract
Background: Predisposition to complex diseases is explained in part by genetic variation, and complex diseases
are frequently comorbid, consistent with pleiotropic genetic variation influencing comorbidity. Genome Wide
Association (GWA) studies typically assess association between SNPs and a single-disease phenotype. Fisher meta-
analysis combines evidence of association from single-disease GWA studies, assuming that each study is an
independent test of the same hypothesis. The Rank Product (RP) method overcomes limitations posed by Fisher
assumptions, though RP was not designed for GWA data.
Methods: We modified RP to accommodate GWA data, and we call it modRP. Using p-values output from GWA
studies, we aggregate evidence for association between SNPs and related phenotypes. To assess significance, RP
randomly samples the observed ranks to develop the null distribution of the RP statistic, and then places the
observed RPs into the null distribution. ModRP eliminates the effect of linkage disequilibrium and controls for
differences in power at tested SNPs, to meet RP assumptions in application to GWA data.
Results: After validating modRP based on both positive and negative control studies, we searched for pleiotropic
influences on comorbid substance use disorders in a novel study, and found two SNPs to be significantly
associated with comorbid cocaine, opium, and nicotine dependence. Placing these SNPs into biological context,
we developed a protein network modeling the interaction of cocaine, nicotine, and opium with these variants.
Conclusions: ModRP is a novel approach to identifying pleiotropic genetic influences on comorbid complex
diseases. It can be used to assess association for related phenotypes where raw data is unavailable or inappropriate
for analysis using other approaches. The method is conceptually simple and produces statistically significant,
biologically relevant results.
Background
Genome Wide Association (GWA) studies typically
assess evidence of association between individual variants
(e.g. SNPs) and a single-disease phenotype. Extending
GWA to assess pleiotropic influences on comorbidity is a
reasonable next-step in complex disease analysis.
Approaches to GWA for comorbid phenotypes that com-
bine raw data may not be possible if the raw data are
unavailable or are inappropriate to combine (e.g., due to
differences in data types or analytical methods). Fisher
meta-analysis [1] combines the p-values from multiple
studies and, if the individual GWA studies to be com-
bined are independent and test the same hypothesis, the
distribution of the Fisher statistic is chi-square. For
comorbidity studies, we considered the related Rank Pro-
duct (RP) approach introduced by Breitling, et al. [2]. RP
combines data from multiple microarray studies, where
samples may not be strictly independent and may test
related hypotheses. Input to the RP method consists of a
table with one column of probe identifiers, and one data
column of ranks (1 to N) for each phenotype tested
based on the fold-change values. The product of the
ranks is calculated (RP statistic) for each row. To assess
significance, the null distribution of the RP statistic is
derived by randomly sampling from the ranks in each
column, and forming many RP statistics. Each observed
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RP statistic is placed into the null distribution, and non-
parametric p-values are calculated. We report here a
modified RP method (modRP) that ensures that we meet
the assumptions of RP in application to GWA by expli-
citly disrupting linkage disequilibrium (LD) and by
grouping SNPs based on minor allele frequency (MAF)
(see supplement for RP assumptions). In this work, we
validated modRP based on available control studies, then
found a novel, statistically significant, biologically rele-
vant association between two SNPs and comorbid sub-
stance dependence phenotypes, providing a model for
this gene-environment interaction and demonstrating the
usefulness of the approach.
Methods
For each analysis, we merged the datasets from indivi-
dual studies by SNP identifier, ranked each column by
p-value, calculated the observed RP for each SNP, and
sorted SNPs by increasing RP. For each SNP, we down-
loaded chromosome position and MAF annotation from
HapMart [3], or used annotation from the original
study. To control for potential differences in power
based on MAF, we grouped SNPs by low, medium, and
high MAF (e.g., MAF < 10%, 10% < MAF < 25%, 25% <
MAF < 50%). ModRP also uses SNP position to restrict
random sampling to SNPs outside the potential range of
LD. For Lind’s data [4] we calculated correlations across
the top 0.1% of SNPs (when ranked by RP), and across
the complete dataset. For Yu’s data [5], we calculated
correlations across the top 0.5% of SNPs, and across the
complete dataset. Details of the assumptions and control
studies, as well as details of the modRP algorithm, are
provided in the supplement.
We used 109 valid iterations (meeting both LD and
MAF requirements) in permutation testing, performed
tests in pairs, and ensured that each pair of tests yielded
essentially the same results. If not, we increased the
number of iterations until the criterion was met. We
report the higher p-value for each pair of results. We
applied a Bonferroni correction to adjust for multiple
hypothesis testing, based on the number of SNPs. For
comparison among methods, for each test we also per-
formed traditional Fisher meta-analysis, modified Fisher
(empirical p-values), and RP. See supplement for effec-
tiveness of modRP and run time.
Results
We first tested modRP using datasets from Lind, et al.
[4], who combined alcohol dependence (AD) and nico-
tine dependence (ND) GWA datasets in a comorbidity
study by developing a chi-square statistic, and applied it
to two populations. This study found significant associa-
tion with the comorbidity in one AD/ND population
(positive control), and did not find evidence in a second
AD/ND population (negative control). Lind’s group
reported significant association between three SNPs
(rs7530302, rs1784300, rs12882384) and comorbid AD/
ND in the Australian population (Table 1). For these
SNPS, results based on modRP are very similar to those
derived by Lind. All three SNPS are significantly asso-
ciated with the comorbid phenotype, though modRP is
slightly more conservative than Lind’s approach. For
rs7530302 and rs12882384, a) the Fisher test result var-
ies from both Lind’s and modRP result, b) the mod-
Fisher result varies from Lind’s values, Fisher, and
modRP and c) RP differs from all of the other results.
Table 1 Comparison of modRP results to control studies
Lind, et al., Published Results Our Results, Corrected Threshold: 6.54E-08
SNP p-value SNP Fisher Mod Fisher RP Mod RP
Australian (Pos Control)
rs7530302 1.90E-09 AD/ND Comorbidity rs7530302 5.29E-08 2.33E-07 5.60E-08 3.39E-08
rs1784300 2.60E-09 rs1784300 1.19E-09 2.00E-09 6.00E-09 3.57E-09
rs12882384 4.86E-08 rs12882384 2.16E-07 5.51E-07 1.08E-07 5.72E-08
Aus/Dutch (Neg Control)
rs2247219 6.23E-06 AD/AD/AD Meta rs2247219 2.22E-05 2.02E-05 1.52E-05 1.41E-05
rs6705087 4.80E-06 ND/ND Meta rs6705087 1.16E-05 1.12E-05 4.02E-06 5.64E-06
N/A AD/ND/AD/AD/ND Co rs1784300 3.31E-08 2.20E-08 1.05E-07 1.27E-07
Yu, et al., Published Results Our Results, corrected Threshold: 8.88E-06
SNP p-value Single Phenotypes (Neg) SNP Fisher Mod Fisher RP Mod RP
rs1938584 3.00E-03 Cocaine rs1476880 1.36E-04 1.41E-04 1.32E-04 1.41E-04
rs1516003 9.00E-04 Opium rs1333962 1.80E-02 1.16E-05 1.01E-05 1.15E-05
rs769592 2.00E-03 Nicotine rs2194 4.20E-02 3.48E-04 3.47E-04 3.47E-04
rs1937443 4.00E-03 Alcohol rs6505380 1.30E-05 1.37E-04 1.48E-04 1.37E-04
Comparison of Lind and Yu results with results from our four tested methods. Tests that satisfied the Bonferroni correction threshold are in bold.
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This effect is not seen for rs1784300, where all five
methods yield a similar level of significance. In the com-
bined Australian/Dutch populations we did not find sig-
nificant association between any SNP and AD or ND
using any of the test methods, consistent with Lind’s
results (Table 1). We then applied modRP to datasets
developed by Yu, et al. [5], who performed meta-ana-
lyses on four single-disease phenotypes (cocaine, opium,
nicotine, and alcohol dependence), in a combined popu-
lation based on African American (AA) and European
American (EA) sub-populations. In replicating Yu’s
meta-analyses, modRP does not find any significant
SNPs, consistent with the other four methods.
In a novel study (Table 2) we assessed evidence for
pleiotropy in four comorbidities, in AA and EA popula-
tions plus the combined population, based on single-
disease p-values output from Yu’s study [5]. In each
case, we checked the four-way (cocaine/opium/nicotine/
alcohol), three-way (e.g., cocaine/opium/nicotine), and
two-way (e.g., cocaine/opium) comorbidities. In the AA
population, we found rs1426165 to be significantly asso-
ciated with cocaine/nicotine dependence comorbidity,
with a p-value of 3.62E-06. This SNP is in the coding
region of the ADAMTSL3 gene (ADAMTS-like 3, a dis-
integrin-like and metalloprotease domain with throm-
bospondin type I motifs-like 3, Entrez GeneID 57188).
In the EA population, we found rs1476880 to be signifi-
cantly associated with cocaine/nicotine comorbidity,
with a p-value of 5.38E-06. This SNP tags the SOD3
gene (superoxide dismutase 3, Entrez GeneID 20657). In
addition, evidence for association of rs1476880 with the
three-way comorbidity of cocaine/opium/nicotine
dependence is even more significant (p-value 2.26E-06),
consistent with an amplified signal in the three-way
comorbidity, and in the combined population. A systems
biology interpretation of these results is provided in the
Table 2 Results from modRP analysis of cocaine (C), opium (O), nicotine (N), and alcohol (A) dependence comorbidities
in Combined, EA, and AA populations.
COMBINED (EA & AA) Population
Four Three Two
CO rs1476880* 3.30E-05
CONA rs1476880 1.55E-05 CON rs1476880* 2.26E-06 CN rs1476880* 5.30E-06 SOD3
CONA rs1426165 2.68E-03 CNA rs1426165 6.87E-04 CN rs1426165 2.97E-04 ADAMTSL3
CONA rs1169791* 1.23E-05 CNA rs1925156* 1.20E-05 CA rs1938584* 3.07E-05
COA rs1938584* 3.35E-05 ON rs1860148* 5.61E-05
ONA rs1385513* 1.07E-04 OA rs726427* 3.66E-04
NA rs2169325* 1.57E-04
EUROPEAN AMERICANS
Four Three Two
CO rs1476880 3.32E-05
CONA rs1476880 1.59E-05 CON rs1476880* 2.23E-06 CN rs1476880* 5.38E-06 SOD3
CONA rs1426165 2.67E-03 CNA rs1426165 6.87E-04 CN rs1426165 2.97E-04 ADAMTSL3
CONA rs1169791* 1.26E-05 CNA rs1925156* 1.20E-05 CA rs1938584* 3.06E-05
COA rs1938584* 3.33E-05 ON rs1860148* 5.61E-05
ONA rs1385513* 1.07E-04 OA rs726427* 3.66E-04
NA rs2169325* 1.57E-04
AFRICAN AMERICANS
Four Three Two
CON rs726344* 2.70E-05 CO rs1015343* 9.50E-05
CONA rs1476880 2.46E-04 CON rs1476880 4.47E-05 CN rs1476880 2.01E-05 SOD3
CONA rs1426165 7.44E-05 CNA rs1426165* 1.73E-05 CN rs1426165* 3.62E-06 ADAMTSL3
COA rs910633* 8.32E-05 CA rs763869* 4.54E-05
ON rs897119* 1.05E-04
CONA rs795734* 5.03E-05 ONA rs795734* 9.12E-06 OA rs795734 7.06E-05
NA rs795734 1.07E-04
In each population, the 4-way (Four), 3-way (Three), and 2-way (Two) comorbidities proceed from left to right. * Indicates the most significant result for each
comorbid phenotype, in each population. For reference, complete results for rs1426165 and rs1476880 are included in each population set. Bonferroni Corrected
Threshold: 8.88e-006
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supplement, using GeneGo’s MetaCore software (Gen-
eGo Inc., St. Joseph, MI).
Discussion
In this work, we introduce modRP, a method to identify
pleiotropic influences on comorbid phenotypes, and com-
pare modRP to four related methods. ModRP combines
summary data from related GWA studies, while control-
ling for minor allele frequency and linkage disequilibrium.
Comparison of modRP performance to studies by Lind, et
al., [4] and Yu, et al.,[5] showed that modRP produces
results consistent with available positive and negative con-
trol studies. While no one knows the “true” genetic influ-
ences in these populations, these comparisons provide
evidence of modRP’s effectiveness in field studies. In the
test study, association of SNP rs1426165 with the cocaine/
opium/nicotine comorbidity highlights the well-developed
body of evidence for the influence of oxidative stress in
substance dependence. Superoxide dismutases catalyze the
dismutation of two superoxide radicals into hydrogen per-
oxide and oxygen and protect tissues from oxidative stress.
SOD3 has not been previously associated with drug abuse,
though there are documented connections between oxida-
tive stress and nicotine [6], heroin [7], and cocaine [8]
dependence. It has been suggested that oxidative mechan-
isms mediate the processes of drug addiction and toxicity
[9,10] and that antioxidants may have therapeutic poten-
tial in managing these conditions. Little has been pub-
lished on ADAMTSL3, although the ADAM gene family
has been associated with multiple diseases induced by
oxidative stress [11,12].
Conclusions
ModRP combines prior evidence of association with
related phenotypes to identify novel variants which may
influence comorbid phenotypes through common
underlying mechanisms. The algorithm uses p-values for
association with single-disease phenotypes as input,
combines this evidence to form a test statistic for each
SNP, and assesses the significance of each test statistic.
Raw data, which may be unavailable or inappropriate for
combining, is not required by modRP. The algorithm
provides significant insight into genetic variation influ-
encing pleiotropy. This work opens the door to analysis
of comorbid or single-disease phenotypes, assessed in a
single population or in independent populations.
Additional material
Additional file 1: Details of the algorithm, control studies and
systems biology. A Word document providing additional details on
assumptions, studies used as controls, and systems biology interpretation.
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